
Designation facilitates data sharing, promotes transparency and trust in clinical research

Public consultation open until end September 2025

Data collection is key in tackling antimicrobial resistance

CHMP recommends five new medicines for approval in the EU

Seizing opportunities in a changing medicines landscape

Patients invited to report suspicious offers
Find medicine
What's new
FAQs
Latest news

Designation facilitates data sharing, promotes transparency and trust in clinical research
Yearly updates to virus strains ensure vaccine effectiveness

Proposal aims to encourage development and improve patient access

Data comes from EU27 plus Iceland and Norway

Five new medicines recommended for approval; another seven medicines recommended for extension of their therapeutic indications
Benefits continue to outweigh risks, with new risk minimisation measures and more information to be provided about long-term effect on the heart
Events
EudraVigilance is the EU's system for managing and analysing information on adverse reactions to medicines which have been authorised or are being studied in clinical trials in the European Economic Area (EEA) and supports the reporting and analysis of suspected adverse reactions originating from clinical trials and the post-authorisation phase of...